ARCHIVES

In Brief: Thomas Davis Is Named New Director Of NCCP; Senate Subcommittee Give NCI $1.2 Bil. For FY ‘86

This article is from The Cancer Letter archive.

Vol. 11 No. 37 | September 27, 1985

Download PDF Visit The Full Archive

Related Articles

Breast Implants Lessen Ability Of Mammograms To Find Cancer

February 27, 2004

Adamson Objects to IOM “Primrose Path of Centralization” In Report

March 3, 1989

FDA Revokes Avastin’s Accelerated Approval In Metastatic Breast Cancer Indication

November 18, 2011

In Brief: DRCA Board Split On Guidelines For CCOP Remains Unresolved; Chop Implementation Talks Starting

December 4, 1981

Health Canada Suspends Avastin Approval; CMS Has Taken No Action After FDA Decision

December 2, 2011

FDA Moves to Regulate Lab-Developed Tests

August 1, 2014